Up-regulation of hormone response of human papillomavirus type 16 expression and increased DNA-protein binding by consensus mutations of viral glucocorticoid response elements

Suvarnalatha Khare, Kotlo U. Kumar, Shou Ching Tang, Mary M. Pater, Alan Pater

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Human papillomaviruses (HPVs) and steroid hormones are linked to the development of cervical cancer. Studies from our laboratory and others showed that the steroid glucocorticoid and progesterone hormones activated the expression of HPV type 16. This activation was attributed to the specific interaction of the glucocorticoid receptor (GR) with the three glucocorticoid response elements (GREs) in the HPV16 regulatory region. In the present study, we first examined the glucocorticoid response mediated through the GREs, using GRE consensus (GREc) mutations and expression assays from a heterologous basal promoter. Both single and triple HPV16 GREc constructs increased expression in the presence of the dexamethasone glucocorticoid in HeLa cervical carcinoma cells and primary baby rat kidney epithelial cells, in comparison with the triple wild-type GREs. Further, the hormone increased significantly the expression of the viral E6-E7 oncogene mRNA from intact HPV in primary human ectocervical cells in in situ hybridization assays. Three in vitro assays of DNA-protein interaction with oligonucleotides and HeLa cell extracts showed a higher binding of protein to two of the HPV16 GREcs than to the wild-type GREs. This applied especially to the GRE containing an overlapping NF1 half site, that also had a greater differential induction by dexamethasone of expression in vivo. The NF1 site was mutated in the GREc that also was bound by unique, lower-mobility complexes in electrophoretic mobility shift assays. UV-crosslinking assays confirmed the increased binding and showed binding by a 96-kDa protein, probably the GR. Our results show an important role of glucocorticoids in HPV16 expression, The direct action through the HPV16 GREs is suggested to be mediated by the hormone-activated GR in association with other factors.

Original languageEnglish (US)
Pages (from-to)254-262
Number of pages9
JournalJournal of Medical Virology
Volume50
Issue number3
DOIs
StatePublished - Nov 1 1996

Fingerprint

Human papillomavirus 16
DNA-Binding Proteins
Response Elements
Glucocorticoids
Up-Regulation
Hormones
Mutation
Glucocorticoid Receptors
Dexamethasone
Steroids
Nucleic Acid Regulatory Sequences
Electrophoretic Mobility Shift Assay
Cell Extracts
HeLa Cells
Oncogenes
Oligonucleotides
Uterine Cervical Neoplasms
In Situ Hybridization
Progesterone
Carrier Proteins

Keywords

  • Consensus
  • GREs
  • Hormone
  • HPV16 transcription
  • Protein-DNA binding

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Up-regulation of hormone response of human papillomavirus type 16 expression and increased DNA-protein binding by consensus mutations of viral glucocorticoid response elements. / Khare, Suvarnalatha; Kumar, Kotlo U.; Tang, Shou Ching; Pater, Mary M.; Pater, Alan.

In: Journal of Medical Virology, Vol. 50, No. 3, 01.11.1996, p. 254-262.

Research output: Contribution to journalArticle

@article{4ffec42915224db18748de7b90a47385,
title = "Up-regulation of hormone response of human papillomavirus type 16 expression and increased DNA-protein binding by consensus mutations of viral glucocorticoid response elements",
abstract = "Human papillomaviruses (HPVs) and steroid hormones are linked to the development of cervical cancer. Studies from our laboratory and others showed that the steroid glucocorticoid and progesterone hormones activated the expression of HPV type 16. This activation was attributed to the specific interaction of the glucocorticoid receptor (GR) with the three glucocorticoid response elements (GREs) in the HPV16 regulatory region. In the present study, we first examined the glucocorticoid response mediated through the GREs, using GRE consensus (GREc) mutations and expression assays from a heterologous basal promoter. Both single and triple HPV16 GREc constructs increased expression in the presence of the dexamethasone glucocorticoid in HeLa cervical carcinoma cells and primary baby rat kidney epithelial cells, in comparison with the triple wild-type GREs. Further, the hormone increased significantly the expression of the viral E6-E7 oncogene mRNA from intact HPV in primary human ectocervical cells in in situ hybridization assays. Three in vitro assays of DNA-protein interaction with oligonucleotides and HeLa cell extracts showed a higher binding of protein to two of the HPV16 GREcs than to the wild-type GREs. This applied especially to the GRE containing an overlapping NF1 half site, that also had a greater differential induction by dexamethasone of expression in vivo. The NF1 site was mutated in the GREc that also was bound by unique, lower-mobility complexes in electrophoretic mobility shift assays. UV-crosslinking assays confirmed the increased binding and showed binding by a 96-kDa protein, probably the GR. Our results show an important role of glucocorticoids in HPV16 expression, The direct action through the HPV16 GREs is suggested to be mediated by the hormone-activated GR in association with other factors.",
keywords = "Consensus, GREs, Hormone, HPV16 transcription, Protein-DNA binding",
author = "Suvarnalatha Khare and Kumar, {Kotlo U.} and Tang, {Shou Ching} and Pater, {Mary M.} and Alan Pater",
year = "1996",
month = "11",
day = "1",
doi = "10.1002/(SICI)1096-9071(199611)50:3<254::AID-JMV8>3.0.CO;2-8",
language = "English (US)",
volume = "50",
pages = "254--262",
journal = "Journal of Medical Virology",
issn = "0146-6615",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Up-regulation of hormone response of human papillomavirus type 16 expression and increased DNA-protein binding by consensus mutations of viral glucocorticoid response elements

AU - Khare, Suvarnalatha

AU - Kumar, Kotlo U.

AU - Tang, Shou Ching

AU - Pater, Mary M.

AU - Pater, Alan

PY - 1996/11/1

Y1 - 1996/11/1

N2 - Human papillomaviruses (HPVs) and steroid hormones are linked to the development of cervical cancer. Studies from our laboratory and others showed that the steroid glucocorticoid and progesterone hormones activated the expression of HPV type 16. This activation was attributed to the specific interaction of the glucocorticoid receptor (GR) with the three glucocorticoid response elements (GREs) in the HPV16 regulatory region. In the present study, we first examined the glucocorticoid response mediated through the GREs, using GRE consensus (GREc) mutations and expression assays from a heterologous basal promoter. Both single and triple HPV16 GREc constructs increased expression in the presence of the dexamethasone glucocorticoid in HeLa cervical carcinoma cells and primary baby rat kidney epithelial cells, in comparison with the triple wild-type GREs. Further, the hormone increased significantly the expression of the viral E6-E7 oncogene mRNA from intact HPV in primary human ectocervical cells in in situ hybridization assays. Three in vitro assays of DNA-protein interaction with oligonucleotides and HeLa cell extracts showed a higher binding of protein to two of the HPV16 GREcs than to the wild-type GREs. This applied especially to the GRE containing an overlapping NF1 half site, that also had a greater differential induction by dexamethasone of expression in vivo. The NF1 site was mutated in the GREc that also was bound by unique, lower-mobility complexes in electrophoretic mobility shift assays. UV-crosslinking assays confirmed the increased binding and showed binding by a 96-kDa protein, probably the GR. Our results show an important role of glucocorticoids in HPV16 expression, The direct action through the HPV16 GREs is suggested to be mediated by the hormone-activated GR in association with other factors.

AB - Human papillomaviruses (HPVs) and steroid hormones are linked to the development of cervical cancer. Studies from our laboratory and others showed that the steroid glucocorticoid and progesterone hormones activated the expression of HPV type 16. This activation was attributed to the specific interaction of the glucocorticoid receptor (GR) with the three glucocorticoid response elements (GREs) in the HPV16 regulatory region. In the present study, we first examined the glucocorticoid response mediated through the GREs, using GRE consensus (GREc) mutations and expression assays from a heterologous basal promoter. Both single and triple HPV16 GREc constructs increased expression in the presence of the dexamethasone glucocorticoid in HeLa cervical carcinoma cells and primary baby rat kidney epithelial cells, in comparison with the triple wild-type GREs. Further, the hormone increased significantly the expression of the viral E6-E7 oncogene mRNA from intact HPV in primary human ectocervical cells in in situ hybridization assays. Three in vitro assays of DNA-protein interaction with oligonucleotides and HeLa cell extracts showed a higher binding of protein to two of the HPV16 GREcs than to the wild-type GREs. This applied especially to the GRE containing an overlapping NF1 half site, that also had a greater differential induction by dexamethasone of expression in vivo. The NF1 site was mutated in the GREc that also was bound by unique, lower-mobility complexes in electrophoretic mobility shift assays. UV-crosslinking assays confirmed the increased binding and showed binding by a 96-kDa protein, probably the GR. Our results show an important role of glucocorticoids in HPV16 expression, The direct action through the HPV16 GREs is suggested to be mediated by the hormone-activated GR in association with other factors.

KW - Consensus

KW - GREs

KW - Hormone

KW - HPV16 transcription

KW - Protein-DNA binding

UR - http://www.scopus.com/inward/record.url?scp=0029824048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029824048&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9071(199611)50:3<254::AID-JMV8>3.0.CO;2-8

DO - 10.1002/(SICI)1096-9071(199611)50:3<254::AID-JMV8>3.0.CO;2-8

M3 - Article

C2 - 8923291

AN - SCOPUS:0029824048

VL - 50

SP - 254

EP - 262

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

IS - 3

ER -